You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lenalidomide (Revlimid)

Showing 1 - 25 of 956
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in New York (carfilzomib, Dexamethasone, Clarithromycin)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • New York, New York
    Weill Cornell Medical College
Apr 10, 2022

Non-Hodgkin Lymphoma Trial in Cologne (Tafasitamab, Lenalidomide, Rituximab)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Cologne, Germany
    University of Cologne
Oct 14, 2022

Multiple Myeloma Trial in Aurora, New York (Clarithromycin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +1 more
Feb 1, 2022

Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Huntsville, Bethesda (Ublituximab,

Terminated
  • Non-Hodgkins Lymphoma
  • +6 more
  • Huntsville, Alabama
  • +1 more
May 5, 2022

Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia(CLL)
  • Small Lymphocytic Lymphoma
  • Hackensack, New Jersey
    Hackensack University Medical Center
Jun 24, 2022

Lenalidomide in Combination With Dexamethasone in Clinical

Active, not recruiting
  • Multiple Myeloma
    • Kirchdorf, Austria
    • +11 more
    May 16, 2022

    Kyprolis® in Combination With Revlimid® and Dexamethasone or

    Recruiting
    • Multiple Myeloma in Relapse
    • Frankfurt, Germany
      Centrum für Hämatologie und Onkologie Bethanien
    Jun 2, 2022

    Lenalidomide / Dexamethasone as First Line Therapy in Multiple

    Active, not recruiting
    • Multiple Myeloma
      • Bochum, Germany
        Hämatologisch-Onkologische Schwerpunktpraxis
      Feb 1, 2022

      Myeloma, Multiple Myeloma Trial in Chicago (Daratumumab, Carfilzomib, Lenalidomide)

      Recruiting
      • Myeloma
      • Multiple Myeloma
      • Chicago, Illinois
        The University of Chicago
      Sep 15, 2021

      Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

      Not yet recruiting
      • Multiple Myeloma
      • Myeloma-Associated Amyloidosis
      • Saint Louis, Missouri
        Washington University School of Medicine
      Apr 6, 2023

      Chronic Lymphocytic Leukemia Trial in Cologne (lenalidomide, Placebo)

      Completed
      • Chronic Lymphocytic Leukemia
      • Cologne, Germany
      • +1 more
      Dec 16, 2021

      Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,

      Recruiting
      • Relapsed/Refractory Follicular Lymphoma
      • Marginal Zone Lymphoma (MZL)
      • Chiang Mai, Thailand
        Chiang Mai University
      Nov 20, 2023

      Multiple Myeloma Trial in Atlanta (Bortezomib, Lenalidomide, Dexamethasone)

      Completed
      • Multiple Myeloma
      • Atlanta, Georgia
        Emory University Winship Cancer Institute
      Nov 1, 2021

      Multiple Myeloma Trial in Boston, Columbus (drug, biological, other)

      Terminated
      • Multiple Myeloma
      • Boston, Massachusetts
      • +1 more
      Nov 14, 2022

      B-cell Non-Hodgkin's Lymphoma Trial (IMM0306, Lenalidomide capsule)

      Not yet recruiting
      • B-cell Non-Hodgkin's Lymphoma
      • (no location specified)
      Mar 6, 2023

      Multiple Myeloma Trial in Augusta (Lenalidomide, Vitamin D - Intensified, Vitamin D - Therapeutic)

      Not yet recruiting
      • Multiple Myeloma
      • Augusta, Georgia
        Georgia Cancer Center at Augusta University
      Apr 26, 2023

      CNS Tumors Trial in Saint Petersburg (25 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®), 50 mg/m2

      Terminated
      Has Results
      • Central Nervous System Tumors
      • 25 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®)
      • +4 more
      • Saint Petersburg, Florida
        Johns Hopkins All Childen's Hospital
      Mar 8, 2021

      Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • (no location specified)
      Jan 20, 2023

      Lymphoma Trial in Houston (Rituximab, Lenalidomide, Valemetostat)

      Not yet recruiting
      • Lymphoma
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 4, 2023

      Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL Trial in Houston (Mosunetuzumab, Polatuzumab vedotin, Tafasitamab)

      Not yet recruiting
      • Hodgkin Lymphoma
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 7, 2022

      Multiple Myeloma Trial in Chicago, Evanston, Ann Arbor (Elotuzumab, Carfilzomib, Lenalidomide)

      Active, not recruiting
      • Multiple Myeloma
      • Chicago, Illinois
      • +2 more
      Nov 12, 2021

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

      Active, not recruiting
      Has Results
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • High Dose Methylprednisolone (HDMP)
      • +2 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 12, 2023

      Alkylating Agent-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in Houston (Laboratory Biomarker

      Completed
      Has Results
      • Alkylating Agent-Related Acute Myeloid Leukemia
      • Secondary Acute Myeloid Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 18, 2022

      Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) Trial in Boston

      Active, not recruiting
      • Langerhans Cell Histiocytosis (LCH)
      • +2 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Aug 26, 2022

      Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

      Recruiting
      • Lymphoma
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 20, 2022